Is it time to Buy before this week’s earning report Aspen Aerogels (NYSE:ASPN)

0
67

Earnings results for Aspen Aerogels (NYSE:ASPN)

Aspen Aerogels last released its earnings data on July 28th, 2021. The construction company reported ($0.23) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.04. The company had revenue of $31.67 million for the quarter, compared to the consensus estimate of $25.35 million. Aspen Aerogels has generated ($0.83) earnings per share over the last year (($0.93) diluted earnings per share). Earnings for Aspen Aerogels are expected to grow in the coming year, from ($0.98) to ($0.70) per share. Aspen Aerogels has confirmed that its next quarterly earnings report will be published on Thursday, October 28th, 2021. Aspen Aerogels will be holding an earnings conference call on Thursday, October 28th at 5:00 PM Eastern. Interested parties can .

Analyst Opinion on Aspen Aerogels (NYSE:ASPN)

According to the issued ratings of 9 analysts in the last year, the consensus rating for Aspen Aerogels stock is Buy based on the current 9 buy ratings for ASPN. The average twelve-month price target for Aspen Aerogels is $43.75 with a high price target of $58.00 and a low price target of $8.00.

on ASPN

Aspen Aerogels has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 9 buy ratings, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $43.75, Aspen Aerogels has a forecasted downside of 6.6% from its current price of $46.84. Aspen Aerogels has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Dividend Strength: Aspen Aerogels (NYSE:ASPN)

Aspen Aerogels does not currently pay a dividend. Aspen Aerogels does not have a long track record of dividend growth.

Insiders buying/selling: Aspen Aerogels (NYSE:ASPN)

In the past three months, Aspen Aerogels insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,569,652.00 in company stock. 13.30% of the stock of Aspen Aerogels is held by insiders. A high percentage of insider ownership can be a sign of company health. 86.38% of the stock of Aspen Aerogels is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Aspen Aerogels (NYSE:ASPN

Earnings for Aspen Aerogels are expected to grow in the coming year, from ($0.98) to ($0.70) per share. The P/E ratio of Aspen Aerogels is -50.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Aspen Aerogels is -50.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Aspen Aerogels has a P/B Ratio of 18.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here